Fermenta Biotech Profit Margin

The latest profit margin for FERMENTA.BO is 11.71% as of June 2026. That compares with 19.81% in the prior-year period — down 40.9% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside Fermenta Biotech's historical trend and sector peers before judging valuation or financial health.

Over the past year, FERMENTA.BO's profit margin moved from 19.81% to 11.71% — a 40.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fermenta Biotech's valuation or profitability profile.

Against Healthcare companies, FERMENTA.BO currently prints 11.71% for profit margin, while the sector average sits near 19.13%. That is roughly 38.8% below the sector mean. Large gaps often invite a closer look at Fermenta Biotech's growth, margins, and balance sheet.

Profit Margin shows how effectively Fermenta Biotech converts resources into returns. At 11.71%, FERMENTA.BO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 19.81% in the prior-year period — down 40.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting FERMENTA.BO's profit margin (11.71%), review year-over-year change from 19.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.